DEFA14A 1 tm243018d2_defa14a.htm DEFA14A






Washington, D.C. 20549




Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. _____)


Filed by the Registrant x
Filed by a Party other than the Registrant ¨


Check the appropriate box:


¨  Preliminary Proxy Statement
¨  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨  Definitive Proxy Statement
x  Definitive Additional Materials
¨  Soliciting Material under Rule14a-12



(Name of Registrant as Specified In Its Charter)


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of Filing Fee (Check all boxes that apply):


x  No fee required.
¨  Fee paid previously with preliminary materials.
¨  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.









Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit Control # V29561-P04828 NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275 FORT LEE, NJ 07024 ATTN: MICHAEL CARSON NUVECTIS PHARMA, INC. 2024 Annual Meeting Vote by June 12, 2024 11:59 PM ET You invested in NUVECTIS PHARMA, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on June 13, 2024. Vote Virtually at the Meeting* June 13, 2024 10:00 AM, EDT Virtually at: *Please check the meeting materials for any special requirements for meeting attendance. Get informed before you vote View the Notice and Proxy Statement and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 30, 2024. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit, (2) call 1-800-579-1639 or (3) send an email to If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.


Vote at Prefer to receive an email instead? While voting on, be sure to click “Delivery Settings”. Voting Items Board Recommends V29562-P04828 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of Directors Nominees: 1a. Kenneth Hoberman For 1b. Matthew Kaplan For 2. Ratify the appointment of Kesselman & Kesselman as our independent registered public accounting firm for the year ending December 31, 2024. For NOTE: Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.